Clinical Trials Logo

Prolapse clinical trials

View clinical trials related to Prolapse.

Filter by:

NCT ID: NCT00695240 Recruiting - Clinical trials for Pelvic Organ Prolapse

Post-Operative Pain Control Using Direct Continuous Bupivacaine Infusion After Pelvic Organ Prolapse Repair

Start date: April 2007
Phase: Phase 2/Phase 3
Study type: Interventional

This prospective randomized controlled study will determine the efficacy of continuous local anesthesia at decreasing pain scores compared to patient controlled analgesia for pelvic organ prolapse procedures including posterior colporrhaphy and sacrospinous ligament fixation.

NCT ID: NCT00679276 Completed - Vaginal Prolapse Clinical Trials

Treatment Outcomes of Vaginal Prolapse Repair

Start date: May 2008
Phase: N/A
Study type: Observational

Chart review conducted on all patients having had Prolift surgery since 2005 by Dr. Lary Sirls, Dr. Predeep Nagaraju and Dr. Kenneth Peters at William Beaumont Hospital.

NCT ID: NCT00676325 Enrolling by invitation - Hernia Clinical Trials

Surgical Treatment To Greater Anterior Vaginal Prolapse

Nazcatcâ„¢
Start date: January 2007
Phase: Phase 4
Study type: Interventional

A RCT study to compare traditional colporrhaphy versus polypropylene mesh in treatment of the anterior vaginal wall prolapse.

NCT ID: NCT00638235 Active, not recruiting - Clinical trials for Pelvic Organ Prolapse

Pelvic Floor Repair Systems for Prolapse Repair

PROPEL
Start date: May 2006
Phase: N/A
Study type: Interventional

1. This is a prospective, single arm, multi-center, post market study, which will be conducted under a common protocol. 2. The primary objective of the study is to evaluate long-term efficacy of the AMS Pelvic Floor Repair System devices for prolapse repair. 3. The study population is female subjects > 21 years of age who require surgical reconstruction of their pelvic floor due to prolapse. 4. The clinical data will be analyzed by comparing post-treatment data with the baseline data, with the subject acting as her own control.The follow-up is for two years after the procedure. 5. Prolapse improvement measured by ICS POP-Q Stage at 12-months will be the primary endpoint of the study. The secondary endpoints include quality of life changes from baseline and adverse event rates.

NCT ID: NCT00597935 Completed - Clinical trials for Pelvic Organ Prolapse (POP)

Operations and Pelvic Muscle Training in the Management of Apical Support Loss: The OPTIMAL Trial

OPTIMAL
Start date: February 2008
Phase: N/A
Study type: Interventional

Pelvic organ prolapse is common among women with a prevalence that has been estimated to be as high as 30%. Pelvic organ prolapse often involves a combination of support defects involving the anterior, posterior and/or apical vaginal segments. While the anterior vaginal wall is the segment most likely to demonstrate recurrent prolapse after reconstructive surgery, reoperations are highest among those who require apical suspension procedures with or without repair of other vaginal segments (12%-33%). Despite the substantial health impact, there is a paucity of high quality evidence to support different practices in the management of prolapse, particularly surgery. Thus, the objectives of the Operations and Pelvic Muscle Training in the Management of Apical Support Loss (OPTIMAL) Trial are: 1. to compare sacrospinous ligament fixation (SSLF) to uterosacral vaginal vault ligament suspension (ULS); and 2. to assess the role of perioperative behavioral therapy/pelvic muscle training (PMT) in women undergoing vaginal surgery for apical or uterine prolapse and stress urinary incontinence.

NCT ID: NCT00581594 Terminated - Clinical trials for Pelvic Organ Prolapse

Traditional vs. Graft-augmented Posterior Colporrhaphy

Start date: January 2006
Phase: N/A
Study type: Interventional

Women who undergo posterior colporrhaphy with graft augmentation will have a lower recurrence of their posterior wall defect than women who undergo a traditional posterior colporrhaphy.

NCT ID: NCT00581412 Completed - Clinical trials for Pelvic Organ Prolapse

Composite Graft Use in Abdominal Sacrocolpopexy Reduces Erosion Rates

Start date: September 2007
Phase: N/A
Study type: Observational

This study is to determine whether the use of a composite biologic/synthetic graft during abdominal sacrocolpopexy leads to a lower rate of erosion while maintaining durability.

NCT ID: NCT00581334 Completed - Clinical trials for Pelvic Organ Prolapse

Robotic-assisted Laparoscopic Sacrocolpopexy

Start date: May 2007
Phase:
Study type: Observational

Robotic-assisted Abdominal Sacrocolpopexy is both a feasible and safe method for apical prolapse repair of the vagina.

NCT ID: NCT00576004 Completed - Clinical trials for Urinary Incontinence

Pelvic Organ Prolapse Repair With or Without Concomitant Burch Colposuspension in Patients With Urinary Incontinence

Start date: January 2002
Phase: N/A
Study type: Interventional

To evaluate the impact of Burch colposuspension (BC), as an anti-incontinence measure, in patients with urinary incontinence (UI) undergoing abdominal surgery for pelvic organ prolapse (POP) repair

NCT ID: NCT00572702 Recruiting - Clinical trials for Pelvic Organ Prolapse

Randomized,Multicentric Study to Treat Prolapse After Hysterectomy With Amreich Procedure or Total Prolift Procedure

Start date: January 2007
Phase: N/A
Study type: Interventional

Head to Head comparison of perioperative complications and secondary the impact of operation techniques with or without mesh on patients suffering from pelvic organ prolapse on quality of life.